Frequent allelic loss at the TOC locus on 17q25.1 in primary breast cancers
Koichi Fukino
Department of Molecular Biology, Institute of Gerontology, Nippon Medical School, Kawasaki, Japan
Department of Neurosurgery, Nippon Medical School, Tokyo, Japan
Search for more papers by this authorAritoshi Iida
Department of Molecular Biology, Institute of Gerontology, Nippon Medical School, Kawasaki, Japan
Search for more papers by this authorAkira Teramoto
Department of Neurosurgery, Nippon Medical School, Tokyo, Japan
Search for more papers by this authorGoi Sakamoto
Department of Pathology, Cancer Institute, Tokyo, Japan
Search for more papers by this authorFujio Kasumi
Department of Surgery, Cancer Institute, Tokyo, Japan
Search for more papers by this authorYusuke Nakamura
Laboratory of Molecular Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan
Search for more papers by this authorCorresponding Author
Mitsuru Emi
Department of Molecular Biology, Institute of Gerontology, Nippon Medical School, Kawasaki, Japan
Department of Molecular Biology, Institute of Gerontology, Nippon Medical School, 1–396, Kosugi-cho, Nakahara-ku, Kawasaki-shi, 211–8533, Japan.Search for more papers by this authorKoichi Fukino
Department of Molecular Biology, Institute of Gerontology, Nippon Medical School, Kawasaki, Japan
Department of Neurosurgery, Nippon Medical School, Tokyo, Japan
Search for more papers by this authorAritoshi Iida
Department of Molecular Biology, Institute of Gerontology, Nippon Medical School, Kawasaki, Japan
Search for more papers by this authorAkira Teramoto
Department of Neurosurgery, Nippon Medical School, Tokyo, Japan
Search for more papers by this authorGoi Sakamoto
Department of Pathology, Cancer Institute, Tokyo, Japan
Search for more papers by this authorFujio Kasumi
Department of Surgery, Cancer Institute, Tokyo, Japan
Search for more papers by this authorYusuke Nakamura
Laboratory of Molecular Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan
Search for more papers by this authorCorresponding Author
Mitsuru Emi
Department of Molecular Biology, Institute of Gerontology, Nippon Medical School, Kawasaki, Japan
Department of Molecular Biology, Institute of Gerontology, Nippon Medical School, 1–396, Kosugi-cho, Nakahara-ku, Kawasaki-shi, 211–8533, Japan.Search for more papers by this authorAbstract
Sporadic breast cancers often show allelic losses on the long arm of chromosome 17. Since the BRCA1 gene lies at 17q21.1 and the TOC locus, associated with esophageal cancer, lies at 17q25.1, either gene could be the target of those losses. We examined both loci in 178 primary breast cancers, using microsatellite markers covering the relevant regions of 17q, and observed allelic losses in 97 tumors (55%). Losses were most frequent at markers around the TOC locus (48% at D17S1839 and 43% at D17S1603), where we identified a distinct commonly deleted region within a 1-cM interval. Another larger, separate commonly deleted region including the BRCA1 gene was also identified, which exhibited 45% of allelic loss (at D17S934). Allelic loss on 17q was more frequent in tumors of the solid-tubular histologic type (P = 0.0129) and in estrogen-negative and progesterone-negative tumors (P = 0.0281 and 0.0196, respectively). The results indicated that BRCA1 and TOC are independent targets of allelic loss on 17q in primary breast cancers, and that inactivation of the TOC locus in particular may play an important role in the genesis of sporadic breast tumors. Genes Chromosomes Cancer 24:345–350, 1999. © 1999 Wiley-Liss, Inc.
REFERENCES
- Albertsen HM, Smith SA, Mazoyer S, Fujimoto E, Stevens J, Williams B, Rodrigues P, Cropp CS, Slijepcevic P, Carlson M, Robertson M, Bradley P, Lawrence E, Harrington T, Mei Sheng Z, Hoopes R, Sternberg N, Brothman A, Callahan R, Ponder BAJ, White R. 1994. A physical map and candidate genes in the BRCA1 region on chromosome 17q12–21. Nat Genet 7: 472–479. Medline
- Couch FJ, Castilla LH, Xu J, Abel KJ, Welcsh P, King SE, Wong L, Ho PP, Merajver S, Brody L, Yin GY, Hayes ST, Gieser LM, Flejter WL, Glover TW, Friedman LS, Lynch ED, Meza JE, King MC, Law DJ, Deaven L, Bowcock AM, Collins FS, Weber BL, Chandrasekharappa SC. 1995. A YAC-, P1-, and cosmid-based physical map of the BRCA1 region on chromosome 17q21. Genomics 25: 264–273. Medline
- Cropp CS, Champeme MH, Lidereau R, Callahan R. 1993. Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted. Cancer Res 53: 5617–5619. Medline
- Cropp CS, Nevanlinna HA, Pyrhonen S, Stenman UH, Salmikangas P, Albertsen H, White R, Callahan R. 1994. Evidence for involvement of BRCA1 in sporadic breast carcinomas. Cancer Res 54: 2548–2551. Medline
- Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J. 1996. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380: 152–154. Medline
- Emi M, Miki Y, Nakamura Y. 1997. Genetic alterations and diagnosis in human breast cancer. Jpn J Hum Genet 42: 34–35.
- Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C, Weaver-Feldhaus J, Ding W, Gholami Z, Soederkvist P, Jhanwar S, Berchuck A, Iglehart JD, Marks J, Ballinger DG, Barrett JC, Skolnick MH, Kamb A, Wiseman R. 1994. BRCA1 mutations in primary breast and ovarian carcinomas. Science 266: 120–122. Medline
-
Harada Y,
Katagiri T,
Ito I,
Akiyama F,
Sakamoto G,
Kasumi F,
Nakamura Y,
Emi M.
1994.
Genetic studies of 457 breast cancers: clinicopathologic parameters compared with genetic alterations.
Cancer
74: 2281–2286.
Medline
10.1002/1097-0142(19941015)74:8<2281::AID-CNCR2820740812>3.0.CO;2-I CAS PubMed Web of Science® Google Scholar
- Horwitz KB. 1993. Mechanisms of hormone resistance in breast cancer. Breast Cancer Res Treat 26: 119–130. Medline
- Iida A, Isobe R, Yoshimoto M, Kasumi F, Nakamura Y, Emi M. 1997. Localization of a breast cancer tumor-suppressor gene to a 3-cM interval within chromosomal region 16p22. Br J Cancer 75: 264–267. Medline
- Ito I, Yoshimoto M, Iwase T, Watanabe S, Katagiri T, Harada Y, Kasumi F, Yasuda S, Mitomi T, Emi M, Nakamura Y. 1995. Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer. Br J Cancer 71: 438–441. Medline
- Japanese Breast Cancer Society. 1989. The general rules for clinical and pathological recording of breast cancer. Jpn Surg 19: 612–632.
-
Kalikin LM,
Qu X,
Frank TS,
Caduff RF,
Svoboda SM,
Law DJ,
Petty EM.
1996.
Detailed deletion analysis of sporadic breast tumors defines an interstitial region of allelic loss on 17q25.
Genes Chromosomes Cancer
17: 64–68.
Medline
10.1002/(SICI)1098-2264(199609)17:1<64::AID-GCC10>3.0.CO;2-H CAS PubMed Web of Science® Google Scholar
- Kalikin LM, Frank TS, Svoboda-Newman SM, Wetzel JC, Cooney KA, Petty EM. 1997. A region of interstitial 17q25 allelic loss in ovarian tumors coincides with a defined region of loss in breast tumors. Oncogene 14: 1991–1994. Medline
- Kelsell DP, Risk JM, Leigh IM, Stevens HP, Ellis A, Hennies HC, Reis A, Weissenbach J, Bishop DT, Spurr NK, Field JK. 1996. Close mapping of the focal non-epidermolytic palmoplantar keratoderma (PPK) locus associated with oesophageal cancer (TOC). Hum Mol Genet 5: 857–860. Medline
-
Matsumoto S,
Kasumi F,
Sakamoto G,
Onda M,
Nakamura Y,
Emi M.
1997.
Detailed deletion mapping of chromosome arm 3p in breast cancer: a 2-cM region on 3p14.3–21.1 and a 5-cM region on 3p24.3–25.1 commonly deleted in tumors.
Genes Chromosomes Cancer
20: 1–7.
Medline
10.1002/(SICI)1098-2264(199711)20:3<268::AID-GCC7>3.0.CO;2-0 CAS PubMed Web of Science® Google Scholar
- Nagai MA, Yamamoto L, Salaorni S, Pacheco MM, Brentani MM, Barbosa EM, Brentani RR, Mazoyer S, Smith SA, Ponder BA, Mulligan LM. 1994a. Detailed deletion mapping of chromosome segment 17q12–21 in sporadic breast tumors. Genes Chromosomes Cancer 11: 58–62.
- Nagai MA, Brentani MM, Marques LA, Brentani RR, Ponder BA. 1994b. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients. Br J Cancer 69: 754–758.
- Nagai MA, Medeiros AC, Brentani MM, Brentani RR, Marques LA, Mazoyer S, Mulligan LM. 1995. Five distinct deleted regions on chromosome 17 defining different subsets of human primary breast tumors. Oncology 52: 448–453. Medline
- Nakamura Y. 1993. Multi-step carcinogenesis of colorectal cancer. Jpn J Hum Genet 38: 23–24.
-
Niederacher D,
Picard F,
van Roeyen C,
An HX,
Bender HG,
Beckmann MW.
1997.
Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis.
Genes Chromosomes Cancer
18: 181–192.
Medline
10.1002/(SICI)1098-2264(199703)18:3<181::AID-GCC5>3.0.CO;2-Y CAS PubMed Web of Science® Google Scholar
- Petty EM, Miller DE, Grant AL, Collins EE, Glover TW, Law DJ. 1996. FISH localization of the soluble thymidine kinase gene (TK1) to human 17q25, a region of chromosomal loss in sporadic breast tumors. Cytogenet Cell Genet 72: 319–321. Medline
-
Plummer SJ,
Paris MJ,
Myles J,
Tubbs R,
Crowe J,
Casey G.
1997.
Four regions of allelic imbalance on 17q12-qter associated with high-grade breast tumors.
Genes Chromosomes Cancer
20: 354–362.
Medline
10.1002/(SICI)1098-2264(199712)20:4<354::AID-GCC6>3.0.CO;2-0 CAS PubMed Web of Science® Google Scholar
- Risk JM, Field EA, Field JK, Whittaker J, Fryer A, Ellis A, Shaw JM, Friedmann PS, Bishop DT, Bodmer J, Leigh IM. 1994. Tylosis oesophageal cancer mapped. Nat Genet 8: 319–321. Medline
- Ruhrberg C, Williamson JA, Sheer D, Watt FM. 1996. Chromosomal localization of the human envoplakin gene (EVPL) to the region of the tylosis oesophageal cancer gene (TOC) on 17q25. Genomics 37: 381–385. Medline
- Saito H, Inazawa J, Saito S, Kasumi F, Koi S, Sagae S, Kudo R, Saito J, Noda K, Nakamura Y. 1993. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors. Cancer Res 53: 3382–3385. Medline
- Sato T, Tanigami A, Yamakawa K, Akiyama F, Kasumi F, Sakamoto G, Nakamura Y. 1990. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res 50: 7184–7189. Medline
- Sato T, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y. 1991. Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res 51: 5794–5799. Medline
-
Tsukamoto K,
Ito N,
Yoshimoto M,
Iwase T,
Tada T,
Kasumi F,
Nakamura Y,
Emi M.
1996.
Two distinct commonly deleted regions on chromosome 13q suggest involvement of BRCA2 and retinoblastoma genes in sporadic breast carcinomas.
Cancer
78: 1929–1934.
Medline
10.1002/(SICI)1097-0142(19961101)78:9<1929::AID-CNCR13>3.0.CO;2-# CAS PubMed Web of Science® Google Scholar
- Yokota T, Matsumoto S, Yoshimoto M, kasumi F, Akiyama F, Sakamoto G, Nakamura Y, Emi M. 1997. Mapping of a breast cancer tumor suppressor gene locus to a 4-cM interval on chromosome 18q21. Jpn J Cancer Res 88: 959–964. Medline